Patriot Financial Group Insurance Agency, LLC Genmab A/S Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$30.95 - $39.68 $2,011 - $2,579	-65 Reduced 15.48%	355 $13,000
Q3 2021 Nov 24, 2021	BUY	$41.55 - $48.72 $2,700 - $3,166	65 Added 18.31%	420 $18,000
Q3 2020 Oct 21, 2020	SELL	$33.07 - $38.68 $16,535 - $19,340	-500 Reduced 58.48%	355 $13,000
Q2 2020 Jul 10, 2020	BUY	$20.05 - $33.89 $14,736 - $24,909	735 Added 612.5%	855 $29,000
Q1 2020 Apr 15, 2020	BUY	$17.15 - $25.22 $2,058 - $3,026	120 New	120 $3,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account